Clinical trial
Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
NCT02157519 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 18, 2015
- Completion date
- December 31, 2016
- Enrollment
- 212 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
adherence to medication regime, cancer